Delhi-based Akums Drugs and Pharmaceuticals Ltd has raised close to ₹8.28 billion from anchor investors ahead of the July 30 Initial Public Offerings (IPO).

The anchor investors of the firm include BlackRock Emerging Frontiers Master Fund Limited, SBI Healthcare Opportunities Fund, SBI Conservative Hybrid Fund, Smallcap World Fund, DSP India Fund and IIFL Asset Management Limited.

Meanwhile, Abu Dhabi Investment Authority (ADIA) has also joined the list of anchor investors. Known for its highly diversified portfolio that spans geographies, asset classes and asset types, enabling the generation of consistent, long-term returns throughout market cycles, the ADIA has a total allocation of ₹500 million and 736,362 shares, besides an anchor investment portion of 6.03%, as per a filing on the Bombay Stock Exchange.

Akums Drugs and Pharma allocated 1,22,05,912 equity shares at ₹679 per share to its anchor investors. The company’s public subscription per share ranges from ₹646 to ₹679. – editor@nrifocus.com